These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10801370)

  • 1. Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis.
    Girolami B; Bernardi E; Prins MH; ten Cate JW; Prandoni P; Simioni P; Andreozzi GM; Girolami A; Büller HR
    Eur J Vasc Endovasc Surg; 2000 Apr; 19(4):370-80. PubMed ID: 10801370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of antithrombotic therapy after infrainguinal bypass grafting: a meta-analysis.
    Collins TC; Souchek J; Beyth RJ
    Am J Med; 2004 Jul; 117(2):93-9. PubMed ID: 15234644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic drugs in the primary medical management of intermittent claudication: a meta-analysis.
    Girolami B; Bernardi E; Prins MH; ten Cate JW; Prandoni P; Hettiarachchi R; Marras E; Stefani PM; Girolami A; Büller HR
    Thromb Haemost; 1999 May; 81(5):715-22. PubMed ID: 10365743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy evaluation of clopidogrel compared to ticlopidine after stent implantation: an updated meta-analysis.
    Casella G; Ottani F; Pavesi PC; Sangiorgio P; Rubboli A; Galvani M; Fontanelli A; Bracchetti D
    Ital Heart J; 2003 Oct; 4(10):677-84. PubMed ID: 14664280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials.
    WAVE Investigators
    Am Heart J; 2006 Jan; 151(1):1-9. PubMed ID: 16368284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet therapy in peripheral occlusive arterial disease.
    Wong S; Appleberg M; Lewis DR
    ANZ J Surg; 2006 May; 76(5):364-72. PubMed ID: 16768698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral arterial procedures and postinterventional prophylaxis.
    Kröger K
    J Endovasc Ther; 2006 Feb; 13(1):32-8. PubMed ID: 16445321
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ
    Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.
    Mehta SR; Yusuf S;
    Eur Heart J; 2000 Dec; 21(24):2033-41. PubMed ID: 11102254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes.
    Lange S; Diehm C; Darius H; Haberl R; Allenberg JR; Pittrow D; Schuster A; von Stritzky B; Tepohl G; Trampisch HJ
    Exp Clin Endocrinol Diabetes; 2004 Nov; 112(10):566-73. PubMed ID: 15578331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular access outcomes and medication use: a USRDS study.
    Yevzlin AS; Conley EL; Sanchez RJ; Young HN; Becker BN
    Semin Dial; 2006; 19(6):535-9. PubMed ID: 17150056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conservative therapy of peripheral arterial occlusive disease].
    Frauchiger B
    Schweiz Rundsch Med Prax; 1990 Dec; 79(50):1560-3. PubMed ID: 2270377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleeding risks of combination vs. single antiplatelet therapy: a meta-analysis of 18 randomized trials comprising 129,314 patients.
    Serebruany VL; Malinin AI; Ferguson JJ; Vahabi J; Atar D; Hennekens CH
    Fundam Clin Pharmacol; 2008 Jun; 22(3):315-21. PubMed ID: 18485150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antithrombotic therapy and follow-up of peripheral arterial occlusive disease].
    Breddin HK
    Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):633-8. PubMed ID: 10666826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins.
    Dagher NN; Modrall JG
    Semin Vasc Surg; 2007 Mar; 20(1):10-4. PubMed ID: 17386359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet therapy for vascular interventions.
    Comerota AJ; Thakur S
    Perspect Vasc Surg Endovasc Ther; 2008 Mar; 20(1):28-35. PubMed ID: 18388025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration.
    BMJ; 1994 Jan; 308(6922):159-68. PubMed ID: 8312766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of antithrombotic agents in peripheral arterial diseases].
    Wütschert R; Bounameaux H
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1551-5. PubMed ID: 9092417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-platelet agents in peripheral vascular surgery].
    Van Damme H; David JL; Limet R
    Rev Med Liege; 1999 Feb; 54(2):109-17. PubMed ID: 10221064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease].
    Scheffler A; Rieger H
    Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):639-44. PubMed ID: 10666827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.